Filtrer par catégorie
- Tous
- Congress
- Blog
- Congrès
- Ressource Scientifique
- Webinaire
- Poster
- Publication scientifique
- Communiqué de Presse
- Couverture presse
- Actualités
Filtrer par catégorie
Poster
22/04/2026
Metastatic Prostate Tumor Model Development and Follow-Up Progression Using Imaging
Modeling late-stage prostate cancer metastasis to improve preclinical assessment of therapeutic candidates in clinically relevant settings.
Poster
21/04/2026
Tools for Utilization of Micro-Organisms as New Therapeutic Weapons Against Cancer
From infection to immune activation: preclinical tools to assess oncolytic viruses and bacteria in clinically relevant cancer models.
Poster
20/04/2026
In Vitro and In Vivo Strategies for Antibody Drug Conjugate Development
Advancing ADC development through integrated preclinical tools, from binding and internalization assays to translational efficacy models.
Poster
20/04/2026
Enhancing Preclinical Insights in Immuno-Oncology with Humanized Mice
Humanized mouse models as a bridge to the clinic, enabling translational assessment of immune-oncology drug candidates.
Blog
14/04/2026
A Closer Look at Astatine-211 in Targeted Alpha Radiotherapy
Understanding astatine-211 in targeted alpha radiotherapy, from high LET precision to radiochemistry, supply, and study design constraints.
Communiqué de Presse
13/04/2026
Oncodesign Services extends collaboration with GIP ARRONAX to strengthen At-211 supply
Oncodesign Services extends its collaboration with GIP ARRONAX to secure access to astatine-211 for targeted radiotherapy programs.
Blog
02/03/2026
Designing Robust In Vivo Bioluminescence Imaging Studies
Why substrate choice matters in bioluminescence imaging. Discover how study design decisions shape sensitivity, data quality, and biological insight.
Blog
02/03/2026
The Complexity Behind Modeling Endometriosis
Why is endometriosis so difficult to model preclinically? The biological and translational challenges behind the data.
Blog
27/02/2026
Functional Readouts as a Bridge Between Inflammation and Patient Experience
Why inflammation research must look beyond lesions to functional impact, with insights from dermatology, lung disease, and endometriosis.
Blog
24/02/2026
Alpha or Beta? Choosing the Right Emitter for Targeted Radiotherapy
What distinguishes alpha and beta emitters in targeted radiotherapy? How radiation range, LET, and radionuclide properties influence efficacy and development.
Blog
28/01/2026
Predicting Clinical Success in Preclinical Inflammatory Gut Disease Research
Insights into preclinical study design for inflammatory gut disease, covering acute vs chronic models, dosing strategies, and clinically relevant endpoints.
Blog
07/01/2026
TRT and Oncological Drugs Acting Together
Discover how targeted radiotherapy combined with oncological drugs is reshaping oncology through synergy, safety and precision medicine